Two patients had frequent attacks of acute myelitis and optic neuritis. One patient lacked any other organ involvement whereas the other developed systemic manifestations of systemic lupus erythematosus 14 years after the onset.
The patient, a 43 year old woman, noted numbness in her left foot and difficulty walking at 27 years of age. At that time, she was found to 
ds DNA antibody were negative. Her CSF showed 7 mononuclear cells/mm3, a protein concentration of 107 mg/dl, and IgG index 0-74 (normal <0 65). MRI showed hyperintensity lesions in the swollen cervical cord (C2 to C7), and hypothalamus and anterior commissure on both sides on the T2 weighted images with enhancement by gadolinium-DTPA. Prednisolone alleviated her manifestations and the ANA became negative.
At 40 years of age, right optic neuritis recurred, ANA was present at 1:160 (speckled type), and an anti-ds DNA antibody test was also positive (3-5 U/ml). A lupus erythematosus test was still negative and C3, C4, and CH 50 were normal. Methylprednisolone pulse treatment gradually alleviated the right visual impairment leaving a large central scotoma.
In both patients, serological tests for syphilis, rheumatoid factor, anti-ribonucleoprotein, anti-Sm, anti-Ki, antimitochondria, anti-SSA, anti-SSB, and anticardiolipin antibodies were negative, whereas the partial thromboplastin time and the activated partial thromboplastin time were normal. The HLA types were A2, A24, B46, B54, Cwl, and DR8 in case 1 and A24, B52, B61, Cw3, DR2, and DR12 in case 2.
Discussion
Both of the patients were initially diagnosed as having relapsing-remitting multiple sclerosis, as they lacked any clinical or laboratory findings of systemic lupus erythematosus. Long after the onset of neurological manifestation, case 1, however, finally met the current diagnostic criteria for systemic lupus erythematosus.4 Similarly, the presence of both ANA and anti-ds DNA antibody was strongly suggestive of systemic lupus erythematosus related collagen disease in case 2.
Interestingly, our patients were remarkably unlike the usual form of systemic lupus erythematosus in several important aspects. Firstly, these patients lacked any clinical or laboratory findings characteristic of systemic lupus erythematosus until either 14 or 18 years after the onset of neurological involvement. Secondly, they had frequent attacks of myelitis and optic neuritis. In systemic lupus erythematosus, the coexistence of myelitis and optic neuritis in a single patient is exceedingly rare,5-7 and, the frequent recurrence of such involvement has never previously been reported.
Our patients had a disease resembling lupoid sclerosis in that the neurological manifestation was a main feature with either no or only minimal evidence of other organ involvement.' Whereas the cases of Fulford et al commonly showed chronic progressive spastic paraparesis,3 our patients instead showed a relapsing-remitting course of the neurological deficits and an involvement of both the optic nerves and spinal cord. Moreover, in the patients of Fulford et al, false positive syphilis serology was prominent, whereas our patients showed neither a false positive syphilis serology nor anticardiolipin antibodies.
We have found no other patients showing any close similarities to our cases in published reports, although there have been two case reports of recurrent myelitis occurring in patients with no other clinical features of systemic lupus erythematosus, but who did present with anti-DNA antibodies instead. 8 9 Taking into account the similarities between these two cases and our patients, there may be a subgroup of patients showing recurrent myelitis and optic neuritis as a main feature associated with anti-DNA antibodies, although it is still possible that multiple sclerosis and systemic lupus erythematosus may, in fact, coexist. Therefore, we propose that the long term finding of an autoantibody profile in patients with relapsing-remitting multiple sclerosis should be considered.
